Effectiveness metrics for the mammography used during phase 1 and AI validation subset
| Techniques evaluated | Clinical validation | Sensitivity | Specificity | PPV | NPV | AUC | F1 score | |
|---|---|---|---|---|---|---|---|---|
| Non-suspicious | BC | |||||||
| Mammography phase 1 | ||||||||
| BI-RADS 1,2 | 2,702 | 1 | 99.19% | 92.03% | 34.45% | 99.96% | N/A | N/A |
| BI-RADS 3–5 | 234 | 123 | π1 | |||||
| AI validation subset | ||||||||
| 0 (non-suspicious) | 19 | 1 | 97.06% | 50.0% | 63.46% | 95.0% | 0.735 | 0.7674 |
| 1 (suspicious) | 19 | 33 | π2 | |||||
Patients with histopathological results; N/A: not applicable